|
Drugmakers Urged to Involve Patients Earlier in Development, Solicit Input on PROs
Drugmakers need to engage patients earlier in the development process to ensure they are addressing the symptoms and measuring the outcomes that matter, patient advocates say.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives